 Marseille, France , Sept. 17, 2021 GLOBE NEWSWIRE -- Innate Pharma SA Euronext Paris: IPH; Nasdaq: IPHA Innate or the Company today announced that AstraZeneca LSESTONasdaq: AZN presented results from the randomized COAST Phase 2 trial during the European Society for Medical Oncology ESMO Congress 2021 on September 17, 2021. 